PH12021552924A1 - Methods of diagnosing and treating cervical cancer - Google Patents
Methods of diagnosing and treating cervical cancerInfo
- Publication number
- PH12021552924A1 PH12021552924A1 PH1/2021/552924A PH12021552924A PH12021552924A1 PH 12021552924 A1 PH12021552924 A1 PH 12021552924A1 PH 12021552924 A PH12021552924 A PH 12021552924A PH 12021552924 A1 PH12021552924 A1 PH 12021552924A1
- Authority
- PH
- Philippines
- Prior art keywords
- methods
- cervical cancer
- diagnosing
- treating cervical
- detection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Optics & Photonics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2019005940A MX380106B (es) | 2019-05-21 | 2019-05-21 | Biomarcadores relacionados a cancer. |
| PCT/IB2020/000395 WO2020234647A2 (fr) | 2019-05-21 | 2020-05-20 | Méthodes de diagnostic et de traitement du cancer du col de l'utérus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12021552924A1 true PH12021552924A1 (en) | 2022-04-11 |
Family
ID=69416620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2021/552924A PH12021552924A1 (en) | 2019-05-21 | 2020-05-20 | Methods of diagnosing and treating cervical cancer |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US11771740B2 (fr) |
| EP (1) | EP3973292A4 (fr) |
| JP (2) | JP7738256B2 (fr) |
| CN (1) | CN113597557A (fr) |
| AU (1) | AU2020280245A1 (fr) |
| BR (1) | BR112021023247A2 (fr) |
| CA (1) | CA3132104A1 (fr) |
| CL (1) | CL2021003005A1 (fr) |
| CO (1) | CO2021015641A2 (fr) |
| MX (1) | MX380106B (fr) |
| PH (1) | PH12021552924A1 (fr) |
| SG (1) | SG11202110101PA (fr) |
| WO (1) | WO2020234647A2 (fr) |
| ZA (2) | ZA202105583B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021163608A2 (fr) * | 2020-02-14 | 2021-08-19 | Galaxy Ccro, Inc. | Dispositifs et procédés de traitement de l'ischémie et des syndromes de détresse respiratoire aiguë |
| CN117694546B (zh) * | 2023-11-24 | 2025-09-19 | 西北农林科技大学 | Fndc1蛋白促进骨骼肌再生和治疗肌肉发育相关疾病的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003295328A1 (en) * | 2002-10-02 | 2004-04-23 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| ATE289685T1 (de) * | 2003-08-25 | 2005-03-15 | Mtm Lab Ag | Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben |
| KR100943525B1 (ko) | 2005-03-18 | 2010-02-22 | (주)지노믹트리 | 바이오마커 스크리닝 시스템 |
| CA2628221A1 (fr) * | 2005-10-31 | 2007-05-10 | Oncomed Pharmaceuticals, Inc. | Anticorps recepteurs fzd destines au traitement du cancer |
| WO2007106425A2 (fr) * | 2006-03-10 | 2007-09-20 | Northeastern University | Procédés protéomiques pour identifier et utiliser des biomarqueurs putatifs associés à un état dysplasique des cellules cervicales ou d'autres types de cellules |
| US20090269731A1 (en) | 2008-04-29 | 2009-10-29 | Burnham Institute For Medical Research | E3-independent ubiquitinylation assay |
| JP5526378B2 (ja) * | 2009-03-05 | 2014-06-18 | 国立大学法人山口大学 | 子宮頸癌の検出方法 |
| EP2417449A4 (fr) | 2009-04-07 | 2016-07-06 | Nexus Dx Inc | Systèmes de dispositif de balayage portatif et procédés permettant de lire des résultats d'analyse hors laboratoire |
| US20110224088A1 (en) * | 2010-03-11 | 2011-09-15 | Heidi Lyng | Biomarkers for subtypes of cervical cancer |
| JP2013099253A (ja) * | 2010-03-11 | 2013-05-23 | Intec Systems Institute Inc | 肺癌または子宮頸癌の診断マーカー |
| WO2013010181A2 (fr) * | 2011-07-14 | 2013-01-17 | University Of Massachusetts | Méthodes de diagnostic du cancer utilisant des biomarqueurs épigénétiques |
| WO2013124738A2 (fr) * | 2012-02-21 | 2013-08-29 | Oslo Universitetssykehus Hf | Méthodes et biomarqueurs permettant de dépister et de pronostiquer le cancer du col utérin |
| JP6366608B2 (ja) * | 2013-01-22 | 2018-08-01 | ネオプロテオミクス アクチボラグ | 癌診断における血小板バイオマーカー |
| US9446148B2 (en) * | 2014-10-06 | 2016-09-20 | Mayo Foundation For Medical Education And Research | Carrier-antibody compositions and methods of making and using the same |
| CN109406785A (zh) | 2017-08-18 | 2019-03-01 | 山东泽济生物科技有限公司 | 肿瘤血液标志物及其应用 |
-
2019
- 2019-05-21 MX MX2019005940A patent/MX380106B/es unknown
-
2020
- 2020-05-20 JP JP2021556203A patent/JP7738256B2/ja active Active
- 2020-05-20 WO PCT/IB2020/000395 patent/WO2020234647A2/fr not_active Ceased
- 2020-05-20 US US16/879,748 patent/US11771740B2/en active Active
- 2020-05-20 PH PH1/2021/552924A patent/PH12021552924A1/en unknown
- 2020-05-20 AU AU2020280245A patent/AU2020280245A1/en not_active Abandoned
- 2020-05-20 CA CA3132104A patent/CA3132104A1/fr active Pending
- 2020-05-20 BR BR112021023247A patent/BR112021023247A2/pt unknown
- 2020-05-20 SG SG11202110101PA patent/SG11202110101PA/en unknown
- 2020-05-20 EP EP20809942.4A patent/EP3973292A4/fr active Pending
- 2020-05-20 CN CN202080018686.0A patent/CN113597557A/zh active Pending
- 2020-10-13 US US17/069,744 patent/US11160844B2/en active Active
-
2021
- 2021-03-11 US US17/199,127 patent/US11160845B2/en active Active
- 2021-08-06 ZA ZA2021/05583A patent/ZA202105583B/en unknown
- 2021-11-15 CL CL2021003005A patent/CL2021003005A1/es unknown
- 2021-11-22 CO CONC2021/0015641A patent/CO2021015641A2/es unknown
-
2022
- 2022-07-07 ZA ZA2022/07531A patent/ZA202207531B/en unknown
-
2023
- 2023-08-23 US US18/454,391 patent/US12433933B2/en active Active
-
2025
- 2025-08-21 JP JP2025138169A patent/JP2025176041A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113597557A (zh) | 2021-11-02 |
| US11160845B2 (en) | 2021-11-02 |
| EP3973292A4 (fr) | 2023-07-26 |
| JP7738256B2 (ja) | 2025-09-12 |
| WO2020234647A2 (fr) | 2020-11-26 |
| WO2020234647A3 (fr) | 2021-03-11 |
| US20210093692A1 (en) | 2021-04-01 |
| US20240091305A1 (en) | 2024-03-21 |
| JP2022533303A (ja) | 2022-07-22 |
| JP2025176041A (ja) | 2025-12-03 |
| US20210015892A1 (en) | 2021-01-21 |
| MX2019005940A (es) | 2019-10-11 |
| MX380106B (es) | 2025-03-12 |
| US11160844B2 (en) | 2021-11-02 |
| CA3132104A1 (fr) | 2020-11-26 |
| CL2021003005A1 (es) | 2022-07-15 |
| BR112021023247A2 (pt) | 2022-01-04 |
| EP3973292A2 (fr) | 2022-03-30 |
| CO2021015641A2 (es) | 2022-01-28 |
| ZA202105583B (en) | 2023-06-28 |
| SG11202110101PA (en) | 2021-10-28 |
| AU2020280245A1 (en) | 2021-12-23 |
| ZA202207531B (en) | 2023-12-20 |
| US12433933B2 (en) | 2025-10-07 |
| US11771740B2 (en) | 2023-10-03 |
| US20210196785A1 (en) | 2021-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY202410A (en) | Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring | |
| CY1122871T1 (el) | Μεθοδος ποσοτικου προσδιορισμου για την εκφραση της pd-l1 | |
| EA201792497A1 (ru) | Антитела к gitr для диагностики злокачественной опухоли | |
| EP4282405A3 (fr) | Détection de biomarqueurs du cancer à l'aide de nanoparticules | |
| WO2014140933A8 (fr) | Procédé de pronostic et de traitement de métastases cancéreuses | |
| PH12017502200A1 (en) | Methods of diagnosing and treating cancer | |
| EP4293358A3 (fr) | Composés organique volatiles utilisé comme biomarqueurs du cancer | |
| EP4234710A3 (fr) | Procédé de diagnostic précis d'une maladie ciblant des biomarqueurs dans une biopsie liquide | |
| BR112017021305A2 (pt) | dispositivo de teste de fluxo lateral, e, método e kit para detecção quantitativa de um analito em uma amostra de saliva | |
| ZA202207531B (en) | Methods of diagnosing and treating cervical cancer | |
| MY179845A (en) | Specific biomarker set for non-invasive diagnosis of liver cancer | |
| EA201070863A1 (ru) | Способы детекции признаков заболеваний или состояний в жидкостях организма | |
| WO2015094995A3 (fr) | Biomarqueurs de signature génique de réponse tumorale à des antagonistes de pd-1 | |
| EP3159695A3 (fr) | Procédé de diagnostic du cancer du pancréas | |
| MX2021006791A (es) | Metodos y composiciones para detectar proteinas mal plegadas. | |
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| EP4220171A3 (fr) | Marqueurs pour le cancer de l'endomètre | |
| WO2015167678A8 (fr) | Nouveaux procédés, tests biologiques, et marqueurs biologiques pour des affections liées au hpv | |
| MX377026B (es) | Biomarcadores para la progresión de enfermedades en melanoma. | |
| WO2020251851A3 (fr) | Biomarqueurs de méthylation de l'adn de diagnostic et de traitement de cancer | |
| MY207814A (en) | Combination of biomarkers for diagnosing of diabetic retinopathy and use thereof | |
| WO2018038352A3 (fr) | Biomarqueur d'auto-anticorps permettant de diagnostiquer la démence et méthode de diagnostic de la démence utilisant celui-ci | |
| WO2014151079A8 (fr) | Biomarqueurs basés sur le rapport et leur procédés d'utilisation | |
| MX2021001522A (es) | Biomarcadores relacionados a cancer. | |
| BR112021022421A2 (pt) | Ensaio multiplex para determinar a razão de ss-amiloide 42/40 em espécimes de plasma humano |